it's about preventing young athletes from taking risks with unproven substances that could have unknown, and potentially catastrophic, long-term health consequences
Not surprisingly, there have been conflicting reports of long-term PPI use and SBP
Patients struggling with depression, autism, anxiety, or treatment resistance are frequently told to check their MTHFR, often with the implication that a single genetic result will explain their symptoms
POOTHULLIL, J., SHIMIZU, A., DAY, R.P., & DOLOVICH, J
Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims that implied sameness with FDA-approved medications
10.1523/JNEUROSCI.2212-10.2011 11 BarreraJ